Global Terbinafine (Lamisil) Market Growth 2020-2025
According to this study, over the next five years the Terbinafine (Lamisil) market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Terbinafine (Lamisil) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Terbinafine (Lamisil) market by type, application, key manufacturers and key regions and countries.
This study considers the Terbinafine (Lamisil) value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Oral
External Use
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Fungal Infection Of The Skin And Mucous Membrane
Onychomycosis
Bronchial Asthma
Gynecological Anti-Infection Preparation
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Perrigo
PLIVA
Novartis Pharmaceuticals Corporation
TEVA
Mylan Pharmaceuticals
Gokul Pharma
Apotex Corporation
Pfizer
Auro Pharma Inc
Sivem Pharmaceuticals
Smaart Pharmaceutticals
Qingdao Jinfeng Pharmaceutical
Qilu Pharmaceutical
Jamp Pharma Corporation
Qd Pharmaceuticals
Codal Synto
Pharmel Inc
Nu Pharm
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Terbinafine (Lamisil) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Terbinafine (Lamisil) market by identifying its various subsegments.
Focuses on the key global Terbinafine (Lamisil) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Terbinafine (Lamisil) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Terbinafine (Lamisil) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Terbinafine (Lamisil) Consumption 2015-2025
2.1.2 Terbinafine (Lamisil) Consumption CAGR by Region
2.2 Terbinafine (Lamisil) Segment by Type
2.2.1 Oral
2.2.2 External Use
2.3 Terbinafine (Lamisil) Consumption by Type
2.3.1 Global Terbinafine (Lamisil) Consumption Market Share by Type (2015-2020)
2.3.2 Global Terbinafine (Lamisil) Revenue and Market Share by Type (2015-2020)
2.3.3 Global Terbinafine (Lamisil) Sale Price by Type (2015-2020)
2.4 Terbinafine (Lamisil) Segment by Application
2.4.1 Fungal Infection Of The Skin And Mucous Membrane
2.4.2 Onychomycosis
2.4.3 Bronchial Asthma
2.4.4 Gynecological Anti-Infection Preparation
2.4.5 Other
2.5 Terbinafine (Lamisil) Consumption by Application
2.5.1 Global Terbinafine (Lamisil) Consumption Market Share by Type (2015-2020)
2.5.2 Global Terbinafine (Lamisil) Value and Market Share by Type (2015-2020)
2.5.3 Global Terbinafine (Lamisil) Sale Price by Type (2015-2020)
3 Global Terbinafine (Lamisil) by Company
3.1 Global Terbinafine (Lamisil) Sales Market Share by Company
3.1.1 Global Terbinafine (Lamisil) Sales by Company (2018-2020)
3.1.2 Global Terbinafine (Lamisil) Sales Market Share by Company (2018-2020)
3.2 Global Terbinafine (Lamisil) Revenue Market Share by Company
3.2.1 Global Terbinafine (Lamisil) Revenue by Company (2018-2020)
3.2.2 Global Terbinafine (Lamisil) Revenue Market Share by Company (2018-2020)
3.3 Global Terbinafine (Lamisil) Sale Price by Company
3.4 Global Terbinafine (Lamisil) Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Terbinafine (Lamisil) Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Terbinafine (Lamisil) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Terbinafine (Lamisil) by Regions
4.1 Terbinafine (Lamisil) by Regions
4.2 Americas Terbinafine (Lamisil) Consumption Growth
4.3 APAC Terbinafine (Lamisil) Consumption Growth
4.4 Europe Terbinafine (Lamisil) Consumption Growth
4.5 Middle East & Africa Terbinafine (Lamisil) Consumption Growth
5 Americas
5.1 Americas Terbinafine (Lamisil) Consumption by Countries
5.1.1 Americas Terbinafine (Lamisil) Consumption by Countries (2015-2020)
5.1.2 Americas Terbinafine (Lamisil) Value by Countries (2015-2020)
5.2 Americas Terbinafine (Lamisil) Consumption by Type
5.3 Americas Terbinafine (Lamisil) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Terbinafine (Lamisil) Consumption by Regions
6.1.1 APAC Terbinafine (Lamisil) Consumption by Regions (2015-2020)
6.1.2 APAC Terbinafine (Lamisil) Value by Regions (2015-2020)
6.2 APAC Terbinafine (Lamisil) Consumption by Type
6.3 APAC Terbinafine (Lamisil) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Terbinafine (Lamisil) by Countries
7.1.1 Europe Terbinafine (Lamisil) Consumption by Countries (2015-2020)
7.1.2 Europe Terbinafine (Lamisil) Value by Countries (2015-2020)
7.2 Europe Terbinafine (Lamisil) Consumption by Type
7.3 Europe Terbinafine (Lamisil) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Terbinafine (Lamisil) by Countries
8.1.1 Middle East & Africa Terbinafine (Lamisil) Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Terbinafine (Lamisil) Value by Countries (2015-2020)
8.2 Middle East & Africa Terbinafine (Lamisil) Consumption by Type
8.3 Middle East & Africa Terbinafine (Lamisil) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Terbinafine (Lamisil) Distributors
10.3 Terbinafine (Lamisil) Customer
11 Global Terbinafine (Lamisil) Market Forecast
11.1 Global Terbinafine (Lamisil) Consumption Forecast (2021-2025)
11.2 Global Terbinafine (Lamisil) Forecast by Regions
11.2.1 Global Terbinafine (Lamisil) Forecast by Regions (2021-2025)
11.2.2 Global Terbinafine (Lamisil) Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Terbinafine (Lamisil) Forecast by Type
11.8 Global Terbinafine (Lamisil) Forecast by Application
12 Key Players Analysis
12.1 Perrigo
12.1.1 Company Information
12.1.2 Terbinafine (Lamisil) Product Offered
12.1.3 Perrigo Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Perrigo Latest Developments
12.2 PLIVA
12.2.1 Company Information
12.2.2 Terbinafine (Lamisil) Product Offered
12.2.3 PLIVA Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 PLIVA Latest Developments
12.3 Novartis Pharmaceuticals Corporation
12.3.1 Company Information
12.3.2 Terbinafine (Lamisil) Product Offered
12.3.3 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Novartis Pharmaceuticals Corporation Latest Developments
12.4 TEVA
12.4.1 Company Information
12.4.2 Terbinafine (Lamisil) Product Offered
12.4.3 TEVA Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 TEVA Latest Developments
12.5 Mylan Pharmaceuticals
12.5.1 Company Information
12.5.2 Terbinafine (Lamisil) Product Offered
12.5.3 Mylan Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Mylan Pharmaceuticals Latest Developments
12.6 Gokul Pharma
12.6.1 Company Information
12.6.2 Terbinafine (Lamisil) Product Offered
12.6.3 Gokul Pharma Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Gokul Pharma Latest Developments
12.7 Apotex Corporation
12.7.1 Company Information
12.7.2 Terbinafine (Lamisil) Product Offered
12.7.3 Apotex Corporation Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Apotex Corporation Latest Developments
12.8 Pfizer
12.8.1 Company Information
12.8.2 Terbinafine (Lamisil) Product Offered
12.8.3 Pfizer Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Pfizer Latest Developments
12.9 Auro Pharma Inc
12.9.1 Company Information
12.9.2 Terbinafine (Lamisil) Product Offered
12.9.3 Auro Pharma Inc Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Auro Pharma Inc Latest Developments
12.10 Sivem Pharmaceuticals
12.10.1 Company Information
12.10.2 Terbinafine (Lamisil) Product Offered
12.10.3 Sivem Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Sivem Pharmaceuticals Latest Developments
12.11 Smaart Pharmaceutticals
12.11.1 Company Information
12.11.2 Terbinafine (Lamisil) Product Offered
12.11.3 Smaart Pharmaceutticals Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Smaart Pharmaceutticals Latest Developments
12.12 Qingdao Jinfeng Pharmaceutical
12.12.1 Company Information
12.12.2 Terbinafine (Lamisil) Product Offered
12.12.3 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Qingdao Jinfeng Pharmaceutical Latest Developments
12.13 Qilu Pharmaceutical
12.13.1 Company Information
12.13.2 Terbinafine (Lamisil) Product Offered
12.13.3 Qilu Pharmaceutical Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Qilu Pharmaceutical Latest Developments
12.14 Jamp Pharma Corporation
12.14.1 Company Information
12.14.2 Terbinafine (Lamisil) Product Offered
12.14.3 Jamp Pharma Corporation Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Jamp Pharma Corporation Latest Developments
12.15 Qd Pharmaceuticals
12.15.1 Company Information
12.15.2 Terbinafine (Lamisil) Product Offered
12.15.3 Qd Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Qd Pharmaceuticals Latest Developments
12.16 Codal Synto
12.16.1 Company Information
12.16.2 Terbinafine (Lamisil) Product Offered
12.16.3 Codal Synto Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Codal Synto Latest Developments
12.17 Pharmel Inc
12.17.1 Company Information
12.17.2 Terbinafine (Lamisil) Product Offered
12.17.3 Pharmel Inc Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Pharmel Inc Latest Developments
12.18 Nu Pharm
12.18.1 Company Information
12.18.2 Terbinafine (Lamisil) Product Offered
12.18.3 Nu Pharm Terbinafine (Lamisil) Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Nu Pharm Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Terbinafine (Lamisil) Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Oral
Table 5. Major Players of External Use
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Terbinafine (Lamisil) Consumption Market Share by Type (2015-2020)
Table 8. Global Terbinafine (Lamisil) Revenue by Type (2015-2020) ($ million)
Table 9. Global Terbinafine (Lamisil) Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Terbinafine (Lamisil) Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Terbinafine (Lamisil) Consumption Market Share by Application (2015-2020)
Table 13. Global Terbinafine (Lamisil) Value by Application (2015-2020)
Table 14. Global Terbinafine (Lamisil) Value Market Share by Application (2015-2020)
Table 15. Global Terbinafine (Lamisil) Sale Price by Application (2015-2020)
Table 16. Global Terbinafine (Lamisil) Sales by Company (2017-2019) (KG)
Table 17. Global Terbinafine (Lamisil) Sales Market Share by Company (2017-2019)
Table 18. Global Terbinafine (Lamisil) Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Terbinafine (Lamisil) Revenue Market Share by Company (2017-2019)
Table 20. Global Terbinafine (Lamisil) Sale Price by Company (2017-2019)
Table 21. Global Terbinafine (Lamisil) Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Terbinafine (Lamisil) Products Offered
Table 23. Terbinafine (Lamisil) Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Terbinafine (Lamisil) Consumption by Regions 2015-2020 (KG)
Table 25. Global Terbinafine (Lamisil) Consumption Market Share by Regions 2015-2020
Table 26. Global Terbinafine (Lamisil) Value by Regions 2015-2020 ($ Millions)
Table 27. Global Terbinafine (Lamisil) Value Market Share by Regions 2015-2020
Table 28. Americas Terbinafine (Lamisil) Consumption by Countries (2015-2020) (KG)
Table 29. Americas Terbinafine (Lamisil) Consumption Market Share by Countries (2015-2020)
Table 30. Americas Terbinafine (Lamisil) Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Terbinafine (Lamisil) Value Market Share by Countries (2015-2020)
Table 32. Americas Terbinafine (Lamisil) Consumption by Type (2015-2020) (KG)
Table 33. Americas Terbinafine (Lamisil) Consumption Market Share by Type (2015-2020)
Table 34. Americas Terbinafine (Lamisil) Consumption by Application (2015-2020) (KG)
Table 35. Americas Terbinafine (Lamisil) Consumption Market Share by Application (2015-2020)
Table 36. APAC Terbinafine (Lamisil) Consumption by Countries (2015-2020) (KG)
Table 37. APAC Terbinafine (Lamisil) Consumption Market Share by Countries (2015-2020)
Table 38. APAC Terbinafine (Lamisil) Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Terbinafine (Lamisil) Value Market Share by Regions (2015-2020)
Table 40. APAC Terbinafine (Lamisil) Consumption by Type (2015-2020) (KG)
Table 41. APAC Terbinafine (Lamisil) Consumption Market Share by Type (2015-2020)
Table 42. APAC Terbinafine (Lamisil) Consumption by Application (2015-2020) (KG)
Table 43. APAC Terbinafine (Lamisil) Consumption Market Share by Application (2015-2020)
Table 44. Europe Terbinafine (Lamisil) Consumption by Countries (2015-2020) (KG)
Table 45. Europe Terbinafine (Lamisil) Consumption Market Share by Countries (2015-2020)
Table 46. Europe Terbinafine (Lamisil) Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Terbinafine (Lamisil) Value Market Share by Countries (2015-2020)
Table 48. Europe Terbinafine (Lamisil) Consumption by Type (2015-2020) (KG)
Table 49. Europe Terbinafine (Lamisil) Consumption Market Share by Type (2015-2020)
Table 50. Europe Terbinafine (Lamisil) Consumption by Application (2015-2020) (KG)
Table 51. Europe Terbinafine (Lamisil) Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Terbinafine (Lamisil) Consumption by Countries (2015-2020) (KG)
Table 53. Middle East & Africa Terbinafine (Lamisil) Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Terbinafine (Lamisil) Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Terbinafine (Lamisil) Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Terbinafine (Lamisil) Consumption by Type (2015-2020) (KG)
Table 57. Middle East & Africa Terbinafine (Lamisil) Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Terbinafine (Lamisil) Consumption by Application (2015-2020) (KG)
Table 59. Middle East & Africa Terbinafine (Lamisil) Consumption Market Share by Application (2015-2020)
Table 60. Terbinafine (Lamisil) Distributors List
Table 61. Terbinafine (Lamisil) Customer List
Table 62. Global Terbinafine (Lamisil) Consumption Forecast by Countries (2021-2025) (KG)
Table 63. Global Terbinafine (Lamisil) Consumption Market Forecast by Regions
Table 64. Global Terbinafine (Lamisil) Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Terbinafine (Lamisil) Value Market Share Forecast by Regions
Table 66. Global Terbinafine (Lamisil) Consumption Forecast by Type (2021-2025) (KG)
Table 67. Global Terbinafine (Lamisil) Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Terbinafine (Lamisil) Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Terbinafine (Lamisil) Value Market Share Forecast by Type (2021-2025)
Table 70. Global Terbinafine (Lamisil) Consumption Forecast by Application (2021-2025) (KG)
Table 71. Global Terbinafine (Lamisil) Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Terbinafine (Lamisil) Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Terbinafine (Lamisil) Value Market Share Forecast by Application (2021-2025)
Table 74. Perrigo Product Offered
Table 75. Perrigo Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 76. Perrigo Main Business
Table 77. Perrigo Latest Developments
Table 78. Perrigo Basic Information, Company Total Revenue (in $ million), Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 79. PLIVA Product Offered
Table 80. PLIVA Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 81. PLIVA Main Business
Table 82. PLIVA Latest Developments
Table 83. PLIVA Basic Information, Company Total Revenue (in $ million), Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 84. Novartis Pharmaceuticals Corporation Product Offered
Table 85. Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 86. Novartis Pharmaceuticals Corporation Main Business
Table 87. Novartis Pharmaceuticals Corporation Latest Developments
Table 88. Novartis Pharmaceuticals Corporation Basic Information, Company Total Revenue (in $ million), Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 89. TEVA Product Offered
Table 90. TEVA Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 91. TEVA Main Business
Table 92. TEVA Latest Developments
Table 93. TEVA Basic Information, Company Total Revenue (in $ million), Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 94. Mylan Pharmaceuticals Product Offered
Table 95. Mylan Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 96. Mylan Pharmaceuticals Main Business
Table 97. Mylan Pharmaceuticals Latest Developments
Table 98. Mylan Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 99. Gokul Pharma Product Offered
Table 100. Gokul Pharma Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 101. Gokul Pharma Main Business
Table 102. Gokul Pharma Latest Developments
Table 103. Gokul Pharma Basic Information, Company Total Revenue (in $ million), Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 104. Apotex Corporation Product Offered
Table 105. Apotex Corporation Basic Information, Company Total Revenue (in $ million), Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 106. Apotex Corporation Main Business
Table 107. Apotex Corporation Latest Developments
Table 108. Apotex Corporation Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 109. Pfizer Product Offered
Table 110. Pfizer Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 111. Pfizer Main Business
Table 112. Pfizer Latest Developments
Table 113. Pfizer Basic Information, Company Total Revenue (in $ million), Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 114. Auro Pharma Inc Product Offered
Table 115. Auro Pharma Inc Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 116. Auro Pharma Inc Main Business
Table 117. Auro Pharma Inc Latest Developments
Table 118. Auro Pharma Inc Basic Information, Company Total Revenue (in $ million), Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 119. Sivem Pharmaceuticals Product Offered
Table 120. Sivem Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 121. Sivem Pharmaceuticals Main Business
Table 122. Sivem Pharmaceuticals Latest Developments
Table 123. Sivem Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Terbinafine (Lamisil) Manufacturing Base, Sales Area and Its Competitors
Table 124. Smaart Pharmaceutticals Product Offered
Table 125. Smaart Pharmaceutticals Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 126. Smaart Pharmaceutticals Main Business
Table 127. Smaart Pharmaceutticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Smaart Pharmaceutticals Latest Developments
Table 129. Qingdao Jinfeng Pharmaceutical Product Offered
Table 130. Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 131. Qingdao Jinfeng Pharmaceutical Main Business
Table 132. Qingdao Jinfeng Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Qingdao Jinfeng Pharmaceutical Latest Developments
Table 134. Qilu Pharmaceutical Product Offered
Table 135. Qilu Pharmaceutical Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 136. Qilu Pharmaceutical Main Business
Table 137. Qilu Pharmaceutical Latest Developments
Table 138. Qilu Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. Jamp Pharma Corporation Product Offered
Table 140. Jamp Pharma Corporation Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 141. Jamp Pharma Corporation Main Business
Table 142. Jamp Pharma Corporation Latest Developments
Table 143. Jamp Pharma Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 144. Qd Pharmaceuticals Product Offered
Table 145. Qd Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 146. Qd Pharmaceuticals Main Business
Table 147. Qd Pharmaceuticals Latest Developments
Table 148. Qd Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 149. Codal Synto Product Offered
Table 150. Codal Synto Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 151. Codal Synto Main Business
Table 152. Codal Synto Latest Developments
Table 153. Codal Synto Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 154. Pharmel Inc Product Offered
Table 155. Pharmel Inc Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 156. Pharmel Inc Main Business
Table 157. Pharmel Inc Latest Developments
Table 158. Pharmel Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 159. Nu Pharm Product Offered
Table 160. Nu Pharm Terbinafine (Lamisil) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2018-2020E)
Table 161. Nu Pharm Main Business
Table 162. Nu Pharm Latest Developments
Table 163. Nu Pharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Terbinafine (Lamisil)
Figure 2. Terbinafine (Lamisil) Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Terbinafine (Lamisil) Consumption Growth Rate 2015-2025 (KG)
Figure 5. Global Terbinafine (Lamisil) Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Oral
Figure 7. Product Picture of External Use
Figure 8. Global Terbinafine (Lamisil) Consumption Market Share by Type (2015-2020)
Figure 9. Global Terbinafine (Lamisil) Value Market Share by Type (2015-2020)
Figure 10. Terbinafine (Lamisil) Consumed in Fungal Infection Of The Skin And Mucous Membrane
Figure 11. Global Terbinafine (Lamisil) Market: Fungal Infection Of The Skin And Mucous Membrane (2015-2020) (KG)
Figure 12. Global Terbinafine (Lamisil) Market: Fungal Infection Of The Skin And Mucous Membrane (2015-2020) ($ Millions)
Figure 13. Terbinafine (Lamisil) Consumed in Onychomycosis
Figure 14. Global Terbinafine (Lamisil) Market: Onychomycosis (2015-2020) (KG)
Figure 15. Global Terbinafine (Lamisil) Market: Onychomycosis (2015-2020) ($ Millions)
Figure 16. Terbinafine (Lamisil) Consumed in Bronchial Asthma
Figure 17. Global Terbinafine (Lamisil) Market: Bronchial Asthma (2015-2020) (KG)
Figure 18. Global Terbinafine (Lamisil) Market: Bronchial Asthma (2015-2020) ($ Millions)
Figure 19. Terbinafine (Lamisil) Consumed in Gynecological Anti-Infection Preparation
Figure 20. Global Terbinafine (Lamisil) Market: Gynecological Anti-Infection Preparation (2015-2020) (KG)
Figure 21. Global Terbinafine (Lamisil) Market: Gynecological Anti-Infection Preparation (2015-2020) ($ Millions)
Figure 22. Terbinafine (Lamisil) Consumed in Other
Figure 23. Global Terbinafine (Lamisil) Market: Other (2015-2020) (KG)
Figure 24. Global Terbinafine (Lamisil) Market: Other (2015-2020) ($ Millions)
Figure 25. Global Terbinafine (Lamisil) Consumption Market Share by Application (2015-2020)
Figure 26. Global Terbinafine (Lamisil) Value Market Share by Application (2015-2020)
Figure 27. Global Terbinafine (Lamisil) Sales Market Share by Company in 2017
Figure 28. Global Terbinafine (Lamisil) Sales Market Share by Company in 2019
Figure 29. Global Terbinafine (Lamisil) Revenue Market Share by Company in 2017
Figure 30. Global Terbinafine (Lamisil) Revenue Market Share by Company in 2019
Figure 31. Global Terbinafine (Lamisil) Sale Price by Company in 2019
Figure 32. Global Terbinafine (Lamisil) Consumption Market Share by Regions 2015-2020
Figure 33. Global Terbinafine (Lamisil) Value Market Share by Regions 2015-2020
Figure 34. Americas Terbinafine (Lamisil) Consumption 2015-2020 (KG)
Figure 35. Americas Terbinafine (Lamisil) Value 2015-2020 ($ Millions)
Figure 36. APAC Terbinafine (Lamisil) Consumption 2015-2020 (KG)
Figure 37. APAC Terbinafine (Lamisil) Value 2015-2020 ($ Millions)
Figure 38. Europe Terbinafine (Lamisil) Consumption 2015-2020 (KG)
Figure 39. Europe Terbinafine (Lamisil) Value 2015-2020 ($ Millions)
Figure 40. Middle East & Africa Terbinafine (Lamisil) Consumption 2015-2020 (KG)
Figure 41. Middle East & Africa Terbinafine (Lamisil) Value 2015-2020 ($ Millions)
Figure 42. Americas Terbinafine (Lamisil) Consumption Market Share by Countries in 2019
Figure 43. Americas Terbinafine (Lamisil) Value Market Share by Countries in 2019
Figure 44. Americas Terbinafine (Lamisil) Consumption Market Share by Type in 2019
Figure 45. Americas Terbinafine (Lamisil) Consumption Market Share by Application in 2019
Figure 46. United States Terbinafine (Lamisil) Consumption Growth 2015-2020 (KG)
Figure 47. United States Terbinafine (Lamisil) Value Growth 2015-2020 ($ Millions)
Figure 48. Canada Terbinafine (Lamisil) Consumption Growth 2015-2020 (KG)
Figure 49. Canada Terbinafine (Lamisil) Value Growth 2015-2020 ($ Millions)
Figure 50. Mexico Terbinafine (Lamisil) Consumption Growth 2015-2020 (KG)
Figure 51. Mexico Terbinafine (Lamisil) Value Growth 2015-2020 ($ Millions)
Figure 52. APAC Terbinafine (Lamisil) Consumption Market Share by Countries in 2019
Figure 53. APAC Terbinafine (Lamisil) Value Market Share by Regions in 2019
Figure 54. APAC Terbinafine (Lamisil) Consumption Market Share by Type in 2019
Figure 55. APAC Terbinafine (Lamisil) Consumption Market Share by Application in 2019
Figure 56. China Terbinafine (Lamisil) Consumption Growth 2015-2020 (KG)
Figure 57. China Terbinafine (Lamisil) Value Growth 2015-2020 ($ Millions)
Figure 58. Japan Terbinafine (Lamisil) Consumption Growth 2015-2020 (KG)
Figure 59. Japan Terbinafine (Lamisil) Value Growth 2015-2020 ($ Millions)
Figure 60. Korea Terbinafine (Lamisil) Consumption Growth 2015-2020 (KG)
Figure 61. Korea Terbinafine (Lamisil) Value Growth 2015-2020 ($ Millions)
Figure 62. Southeast Asia Terbinafine (Lamisil) Consumption Growth 2015-2020 (KG)
Figure 63. Southeast Asia Terbinafine (Lamisil) Value Growth 2015-2020 ($ Millions)
Figure 64. India Terbinafine (Lamisil) Consumption Growth 2015-2020 (KG)
Figure 65. India Terbinafine (Lamisil) Value Growth 2015-2020 ($ Millions)
Figure 66. Australia Terbinafine (Lamisil) Consumption Growth 2015-2020 (KG)
Figure 67. Australia Terbinafine (Lamisil) Value Growth 2015-2020 ($ Millions)
Figure 68. Europe Terbinafine (Lamisil) Consumption Market Share by Countries in 2019
Figure 69. Europe Terbinafine (Lamisil) Value Market Share by Countries in 2019
Figure 70. Europe Terbinafine (Lamisil) Consumption Market Share by Type in 2019
Figure 71. Europe Terbinafine (Lamisil) Consumption Market Share by Application in 2019
Figure 72. Germany Terbinafine (Lamisil) Consumption Growth 2015-2020 (KG)
Figure 73. Germany Terbinafine (Lamisil) Value Growth 2015-2020 ($ Millions)
Figure 74. France Terbinafine (Lamisil) Consumption Growth 2015-2020 (KG)
Figure 75. France Terbinafine (Lamisil) Value Growth 2015-2020 ($ Millions)
Figure 76. UK Terbinafine (Lamisil) Consumption Growth 2015-2020 (KG)
Figure 77. UK Terbinafine (Lamisil) Value Growth 2015-2020 ($ Millions)
Figure 78. Italy Terbinafine (Lamisil) Consumption Growth 2015-2020 (KG)
Figure 79. Italy Terbinafine (Lamisil) Value Growth 2015-2020 ($ Millions)
Figure 80. Russia Terbinafine (Lamisil) Consumption Growth 2015-2020 (KG)
Figure 81. Russia Terbinafine (Lamisil) Value Growth 2015-2020 ($ Millions)
Figure 82. Middle East & Africa Terbinafine (Lamisil) Consumption Market Share by Countries in 2019
Figure 83. Middle East & Africa Terbinafine (Lamisil) Value Market Share by Countries in 2019
Figure 84. Middle East & Africa Terbinafine (Lamisil) Consumption Market Share by Type in 2019
Figure 85. Middle East & Africa Terbinafine (Lamisil) Consumption Market Share by Application in 2019
Figure 86. Egypt Terbinafine (Lamisil) Consumption Growth 2015-2020 (KG)
Figure 87. Egypt Terbinafine (Lamisil) Value Growth 2015-2020 ($ Millions)
Figure 88. South Africa Terbinafine (Lamisil) Consumption Growth 2015-2020 (KG)
Figure 89. South Africa Terbinafine (Lamisil) Value Growth 2015-2020 ($ Millions)
Figure 90. Israel Terbinafine (Lamisil) Consumption Growth 2015-2020 (KG)
Figure 91. Israel Terbinafine (Lamisil) Value Growth 2015-2020 ($ Millions)
Figure 92. Turkey Terbinafine (Lamisil) Consumption Growth 2015-2020 (KG)
Figure 93. Turkey Terbinafine (Lamisil) Value Growth 2015-2020 ($ Millions)
Figure 94. GCC Countries Terbinafine (Lamisil) Consumption Growth 2015-2020 (KG)
Figure 95. GCC Countries Terbinafine (Lamisil) Value Growth 2015-2020 ($ Millions)
Figure 96. Global Terbinafine (Lamisil) Consumption Growth Rate Forecast (2021-2025) (KG)
Figure 97. Global Terbinafine (Lamisil) Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 98. Americas Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 99. Americas Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 100. APAC Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 101. APAC Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 102. Europe Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 103. Europe Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 104. Middle East & Africa Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 105. Middle East & Africa Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 106. United States Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 107. United States Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 108. Canada Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 109. Canada Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 110. Mexico Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 111. Mexico Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 112. Brazil Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 113. Brazil Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 114. China Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 115. China Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 116. Japan Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 117. Japan Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 118. Korea Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 119. Korea Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 120. Southeast Asia Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 121. Southeast Asia Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 122. India Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 123. India Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 124. Australia Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 125. Australia Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 126. Germany Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 127. Germany Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 128. France Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 129. France Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 130. UK Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 131. UK Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 132. Italy Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 133. Italy Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 134. Russia Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 135. Russia Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 136. Spain Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 137. Spain Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 138. Egypt Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 139. Egypt Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 140. South Africa Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 141. South Africa Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 142. Israel Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 143. Israel Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 144. Turkey Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 145. Turkey Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 146. GCC Countries Terbinafine (Lamisil) Consumption 2021-2025 (KG)
Figure 147. GCC Countries Terbinafine (Lamisil) Value 2021-2025 ($ Millions)
Figure 148. Perrigo Terbinafine (Lamisil) Market Share (2018-2020)
Figure 149. PLIVA Terbinafine (Lamisil) Market Share (2018-2020)
Figure 150. Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Market Share (2018-2020)
Figure 151. TEVA Terbinafine (Lamisil) Market Share (2018-2020)
Figure 152. Mylan Pharmaceuticals Terbinafine (Lamisil) Market Share (2018-2020)
Figure 153. Gokul Pharma Terbinafine (Lamisil) Market Share (2018-2020)
Figure 154. Apotex Corporation Terbinafine (Lamisil) Market Share (2018-2020)
Figure 155. Pfizer Terbinafine (Lamisil) Market Share (2018-2020)
Figure 156. Auro Pharma Inc Terbinafine (Lamisil) Market Share (2018-2020)
Figure 157. Sivem Pharmaceuticals Terbinafine (Lamisil) Market Share (2018-2020)
Figure 158. Smaart Pharmaceutticals Terbinafine (Lamisil) Market Share (2018-2020)
Figure 159. Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Market Share (2018-2020)
Figure 160. Qilu Pharmaceutical Terbinafine (Lamisil) Market Share (2018-2020)
Figure 161. Jamp Pharma Corporation Terbinafine (Lamisil) Market Share (2018-2020)
Figure 162. Qd Pharmaceuticals Terbinafine (Lamisil) Market Share (2018-2020)
Figure 163. Codal Synto Terbinafine (Lamisil) Market Share (2018-2020)
Figure 164. Pharmel Inc Terbinafine (Lamisil) Market Share (2018-2020)
Figure 165. Nu Pharm Terbinafine (Lamisil) Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets